Perspective Therapeutics Inc. (CATX) — Cash Flow Reinvestment Rate

Latest as of September 2024: 17.66x

Perspective Therapeutics Inc. (CATX) has a Cash Flow Reinvestment Rate of 17.66x as of September 2024, reinvesting $59.45 Million (capex $29.71 Million plus investments $-29.74 Million) from operating cash flow of $3.37 Million. See financial flexibility index of Perspective Therapeutics Inc. to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

17.66x
(Capex + Investments) / Operating CF

Total Reinvested

$59.45 Million
Capex + Investments

Operating Cash Flow

$3.37 Million
USD

Capital Expenditures

$29.71 Million
USD

Perspective Therapeutics Inc. Cash Flow Reinvestment Rate (1999–2001)

Historical reinvestment intensity for Perspective Therapeutics Inc. across 4 annual periods. Explore Perspective Therapeutics Inc. (CATX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Perspective Therapeutics Inc. (1999–2001)

Year-by-year capital reinvestment analysis for Perspective Therapeutics Inc.. For the full cash flow conversion analysis, see cash flow conversion of Perspective Therapeutics Inc..

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2001 0.13x $48.81K $365.34K $48.81K ▲ +0.0%
2000 0.13x $48.81K $365.34K $48.81K ▼ -76.9%
1999 0.58x $159.58K $275.97K $159.58K ▲ +0.0%
1999 0.58x $159.58K $275.97K $159.58K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow